ID

15829

Descripción

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy; ODM derived from: https://clinicaltrials.gov/show/NCT02252978

Link

https://clinicaltrials.gov/show/NCT02252978

Palabras clave

Versiones (1)
  1. 15/6/16 15/6/16 -
Subido en

15 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT02252978

Inglés

Eligibility Prostate Cancer NCT02252978

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
abnormal serum psa (total > 2.5 ng/ml or other clinically important biomarker parameters, including psa velocity and density) associated with or without normal digital rectal examination
Descripción

Prostate specific antigen measurement Abnormal | Biological Marker parameter | PSA Velocity | Prostate-Specific Antigen density | Digital Rectal Examination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0201544
UMLS CUI [1,2]
C0205161
UMLS CUI [2,1]
C0005516
UMLS CUI [2,2]
C0449381
UMLS CUI [3]
C1518823
UMLS CUI [4,1]
C0138741
UMLS CUI [4,2]
C0178587
UMLS CUI [5]
C1384593
men who have elected to proceed with a diagnostic prostate biopsy
Descripción

Gender | Biopsy of prostate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0194804
any prostate size
Descripción

prostate size Any

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0426731
UMLS CUI [1,2]
C1552551
willingness and ability to give informed consent
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of prostate cancer
Descripción

history of Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332119
UMLS CUI [1,2]
C0600139
urine culture positive for significant urinary tract infection (uti)
Descripción

Culture urine positive Urinary tract infection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0241582
UMLS CUI [1,2]
C0042029
a history of antibiotic use within one month prior to initial psa level measurement
Descripción

Antibiotics Use of | Prostate specific antigen measurement Initial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003232
UMLS CUI [1,2]
C1524063
UMLS CUI [2,1]
C0201544
UMLS CUI [2,2]
C0205265
allergy to fluoroquinolones
Descripción

Hypersensitivity Fluoroquinolones

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0949665
currently taking imperative medications with significant drug-drug interaction with ciprofloxacin
Descripción

Pharmaceutical Preparations | Drug Interaction Ciprofloxacin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013227
UMLS CUI [2,1]
C0687133
UMLS CUI [2,2]
C0008809
compromised renal function with estimated glomerular filtration rate (gfr) of < 30 ml/min/1.73m^2
Descripción

Renal Insufficiency | Estimated Glomerular Filtration Rate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C3811844
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT02252978

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate specific antigen measurement Abnormal | Biological Marker parameter | PSA Velocity | Prostate-Specific Antigen density | Digital Rectal Examination
Item
abnormal serum psa (total > 2.5 ng/ml or other clinically important biomarker parameters, including psa velocity and density) associated with or without normal digital rectal examination
boolean
C0201544 (UMLS CUI [1,1])
C0205161 (UMLS CUI [1,2])
C0005516 (UMLS CUI [2,1])
C0449381 (UMLS CUI [2,2])
C1518823 (UMLS CUI [3])
C0138741 (UMLS CUI [4,1])
C0178587 (UMLS CUI [4,2])
C1384593 (UMLS CUI [5])
Gender | Biopsy of prostate
Item
men who have elected to proceed with a diagnostic prostate biopsy
boolean
C0079399 (UMLS CUI [1])
C0194804 (UMLS CUI [2])
prostate size Any
Item
any prostate size
boolean
C0426731 (UMLS CUI [1,1])
C1552551 (UMLS CUI [1,2])
Informed consent
Item
willingness and ability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
history of Prostate carcinoma
Item
history of prostate cancer
boolean
C0332119 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Culture urine positive Urinary tract infection
Item
urine culture positive for significant urinary tract infection (uti)
boolean
C0241582 (UMLS CUI [1,1])
C0042029 (UMLS CUI [1,2])
Antibiotics Use of | Prostate specific antigen measurement Initial
Item
a history of antibiotic use within one month prior to initial psa level measurement
boolean
C0003232 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2,1])
C0205265 (UMLS CUI [2,2])
Hypersensitivity Fluoroquinolones
Item
allergy to fluoroquinolones
boolean
C0020517 (UMLS CUI [1,1])
C0949665 (UMLS CUI [1,2])
Pharmaceutical Preparations | Drug Interaction Ciprofloxacin
Item
currently taking imperative medications with significant drug-drug interaction with ciprofloxacin
boolean
C0013227 (UMLS CUI [1])
C0687133 (UMLS CUI [2,1])
C0008809 (UMLS CUI [2,2])
Renal Insufficiency | Estimated Glomerular Filtration Rate
Item
compromised renal function with estimated glomerular filtration rate (gfr) of < 30 ml/min/1.73m^2
boolean
C1565489 (UMLS CUI [1])
C3811844 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial